| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0078-0697-61 | 0078-0697 | HUMAN PRESCRIPTION DRUG | PROMACTA | eltrombopag olamine | POWDER, FOR SUSPENSION | ORAL | 20200327 | N/A | NDA | NDA207027 | Novartis Pharmaceuticals Corporation | ELTROMBOPAG OLAMINE | 25 mg/1 | 1 CARTON in 1 KIT (0078-0697-61) / 30 PACKET in 1 CARTON (0078-0697-23) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0697-19) |
| 0078-0972-61 | 0078-0972 | HUMAN PRESCRIPTION DRUG | PROMACTA | eltrombopag olamine | POWDER, FOR SUSPENSION | ORAL | 20180927 | N/A | NDA | NDA207027 | Novartis Pharmaceuticals Corporation | ELTROMBOPAG OLAMINE | 12.5 mg/1 | 1 CARTON in 1 KIT (0078-0972-61) / 30 PACKET in 1 CARTON (0078-0972-23) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0972-19) |